1116099-07-0 Usage
Uses
Used in Pharmaceutical Industry:
3,5-difluoro-4-iodopyridine is utilized as a key intermediate in the synthesis of various biologically active molecules, contributing to the development of new drugs. Its unique structure allows for the creation of compounds with specific therapeutic properties, making it a crucial component in medicinal chemistry research.
Used in Agrochemical Industry:
In the agrochemical sector, 3,5-difluoro-4-iodopyridine serves as a precursor for the development of crop protection agents. Its chemical properties enable the production of compounds with pesticidal or herbicidal activities, thereby enhancing crop yields and protecting them from various pests and diseases.
Used in Organic Synthesis:
3,5-difluoro-4-iodopyridine is employed as a versatile building block in organic synthesis, facilitating the creation of a wide range of chemical compounds. Its reactivity and structural features make it an indispensable tool for chemists in the synthesis of complex organic molecules for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1116099-07-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,6,0,9 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1116099-07:
(9*1)+(8*1)+(7*1)+(6*6)+(5*0)+(4*9)+(3*9)+(2*0)+(1*7)=130
130 % 10 = 0
So 1116099-07-0 is a valid CAS Registry Number.
1116099-07-0Relevant academic research and scientific papers
ACYLGUANIDINE DERIVATIVE
-
Page/Page column 13, (2012/01/03)
An object of the present invention is to provide an excellent agent for treating or preventing dementia, schizophrenia based on a serotonin 5-HT5A receptor modulating action. It was confirmed that acylguanidine derivatives, which has the charac
SUBSTITUTED ACYLGUANIDINE DERIVATIVE
-
Page/Page column 10, (2012/01/03)
An object of the present invention is to provide an excellent agent for treating or preventing dementia, schizophrenia based on serotonin 5-HT5A receptor modulating action. It was discovered that acylguanidine derivatives, in which the guanidin
BICYCLIC ACYLGUANIDINE DERIVATIVE
-
Page/Page column 18; 19, (2010/05/13)
An object of the present invention is to provide a novel and excellent agent for treating or preventing dementia, schizophrenia, and the like, based on the serotonin 5-HT5A receptor modulating action. It was confirmed that a bicyclic acylguanidine derivative which has a characteristic structure that guanidine is bonded to one ring of a bicyclic structure such as chromene and dihydronaphthalene through a carbonyl group and a cyclic group is bonded on the other ring, has a potent 5-HT5A receptor modulating action and an excellent pharmacological action based on this mechanism. The present invention is useful as an excellent agent for treating or preventing dementia, schizophrenia, bipolar disorder, or attention deficit hyperactivity disorder.
